Provided by Tiger Fintech (Singapore) Pte. Ltd.

Soleno Therapeutics

70.25
+0.25000.36%
Volume:1.10M
Turnover:76.58M
Market Cap:3.22B
PE:-16.05
High:70.36
Open:69.79
Low:68.27
Close:70.00
Loading ...

Soleno Therapeutics price target raised to $105 from $75 at Laidlaw

TIPRANKS
·
27 Mar

US Equity Futures Waver Pre-Bell as Traders Digest Q4 GDP

MT Newswires Live
·
27 Mar

Soleno price target raised to $123 at Cantor Fitzgerald after VYKAT XR approved

TIPRANKS
·
27 Mar

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug

Zacks
·
27 Mar

Soleno jumps as analysts say US nod for rare disease drug transforms treatment options

Reuters
·
27 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Alphabet, GameStop

Reuters
·
27 Mar

Soleno's FDA Green Light Seen as Significant Win -- Market Talk

Dow Jones
·
27 Mar

Update: Soleno Therapeutics Secures FDA Approval for Hyperphagia Treatment; Shares Surge Premarket

MT Newswires Live
·
27 Mar

Soleno Shares Soar Premarket on FDA Approval of Vykat XR

Dow Jones
·
27 Mar

US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert

Benzinga
·
27 Mar

BUZZ-Soleno gains as US FDA approves its drug to treat rare genetic disorder

Reuters
·
27 Mar

Soleno Therapeutics Shares up 31.5% Premarket After US FDA Approved Co's Drug to Treat a Rare Genetic Disorder

THOMSON REUTERS
·
27 Mar

Soleno Therapeutics Inc : Baird Raises Target Price to $102 From $72

THOMSON REUTERS
·
27 Mar

Soleno Therapeutics up 35% afterhours following resumption of trading

TIPRANKS
·
27 Mar

Soleno Therapeutics trading resumes

TIPRANKS
·
27 Mar

Soleno Therapeutics Secures FDA Approval for Drug to Treat Hyperphagia

MT Newswires Live
·
27 Mar

Soleno Gets FDA Approval for Hyperphagia Drug

Dow Jones
·
27 Mar

Soleno Therapeutics announces FDA approval of VYKATTM XR to treat hyperphagia

TIPRANKS
·
27 Mar

Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome

GlobeNewswire
·
27 Mar

US FDA greenlights first ever treatment for rare metabolic disorder

Reuters
·
27 Mar